VAERS reports by lot

Pfizer COVID-19 lot HG4589: VAERS reports

48 VAERS reports list lot HG4589 as a Pfizer COVID-19 vaccine, received between 2023-10-26 and 2024-06-17. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
48
Reports
15%
Marked serious
1
With a death outcome
8
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Neurological2017%
General / Systemic (non-local)1815%
Injection-site / Local reaction1513%
Cardiac / Cardiovascular1412%
Dermatological (non-injection-site)1311%
Allergic / Anaphylactic108%
Musculoskeletal108%
Respiratory87%
Gastrointestinal76%
Psychiatric / Neuropsychiatric22%
Reproductive / Menstrual11%

Where reports came from

U.S. state of the reporter, where given (top 12).

California7
Missouri5
New York5
Massachusetts3
New Jersey3
Virginia3
North Carolina3
Mississippi2
Pennsylvania2
Indiana2
Colorado1
Oklahoma1

Reports by month received

2023-104
2023-1116
2023-1215
2024-015
2024-021
2024-041
2024-052
2024-064

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.